DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The "Non-small Cell Lung Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report on global non-small cell lung cancer therapeutics market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global non-small cell lung cancer therapeutics market to grow with a CAGR of 8% over the forecast period of 2018-2024.

The study on non-small cell lung cancer therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

Global Non-small Cell Lung Cancer Therapeutics Market by Drug Class:

Angiogenesis Inhibitor Kinase Inhibitor Epidermal Growth Factor Receptor Blocker Folate Antimetabolites PD-1/PD-L1 Inhibitor Microtubule Stabilizer

How this report delivers:

1. Comprehensive analysis of global as well as regional markets of non-small cell lung cancer therapeutics market.

2. Complete coverage of all the segments in non-small cell lung cancer therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in global non-small cell lung cancer therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Non-small Cell Lung Cancer Therapeutics Market Overview

4. Global Non-small Cell Lung Cancer Therapeutics Market by Drug Class

5. Global Non-small Cell Lung Cancer Therapeutics Market by Region 2018-2024

6. Company Covered

Companies Featured:

Celgene Corporation Bristol-Myers Squibb Novartis AG Eli Lilly Pfizer straZeneca plc Merck KGaA, F. Hoffmann-La Roche Ltd AstraZeneca Orion Corporation

For more information about this report visit https://www.researchandmarkets.com/research/wpqx8v/nonsmall_cell?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005185/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Lung Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/13/2018 08:10 AM/DISC: 07/13/2018 08:10 AM

http://www.businesswire.com/news/home/20180713005185/en